Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm.
Among implantable cardioverter-defibrillator (ICD) recipients, there are patients with recurrent episodes of electrical storm (ES), retractable to the optimal antiarrhythmic drug therapy or invasive ablation procedures. A relatively novel anti-ischemic drug with also antiarrhythmic properties, ranolazine, may effectively suppress ventricular arrhythmias in such patients for a long period of time.
['Margos|Panagiotis|P|0000-0001-6327-5130', 'Margos|Nikolaos|N|', 'Mokadem|Nadiya|N|', 'Patsiotis|Ilias|I|', 'Kranidis|Athanasios|A|']
ranolazine electrical storm Antiarrhythmic defibrillator